Boston Scientific Corporation
Clinical trials sponsored by Boston Scientific Corporation, explained in plain language.
-
Freezing heart tissue to stop AFib: new device under study
Disease control CompletedThis study tests a device that freezes small areas of heart tissue to treat paroxysmal atrial fibrillation (AFib), a condition where the heart beats irregularly. About 200 people with AFib that hasn't responded to medication will receive the procedure. Researchers will track safe…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New gel blocks blood flow to tumors and stops bleeding
Disease control CompletedThis study looked at how well a gel-like material called Obsidio works to block blood vessels in people with hypervascular tumors or bleeding. 125 adults were treated, and researchers checked if the vessels were successfully blocked and if there were any serious side effects with…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for stroke prevention: device offers alternative to blood thinners for heart patients
Disease control CompletedThis study tested the WATCHMAN device, a small implant that closes off a part of the heart where clots often form, in 481 people with atrial fibrillation who cannot take blood thinners. The goal was to see if the device is safe and effective at reducing stroke risk. Participants …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Heart stent study tracks outcomes in over 2,000 chinese patients
Disease control CompletedThis study looked at how well the PROMUS PREMIER stent works in everyday medical practice in China. Over 2,000 people with coronary artery disease received the stent and were followed for 12 months to track major heart problems like heart attacks or the need for another procedure…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New stent helps people with leg artery disease walk better and feel better
Disease control CompletedThis study looked at how well the ELUVIA drug-coated stent works in real-world patients with blocked arteries in the thigh or knee area. A total of 291 adults received the stent and were followed for two years. The main goal was to see if their quality of life and walking ability…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New ablation technique shows promise in Long-Term AFib control
Disease control CompletedThis study followed 364 people with paroxysmal atrial fibrillation (a type of irregular heartbeat) who had already received ablation treatment in a previous trial. Researchers compared a newer pulsed field ablation system with traditional thermal ablation to see how well each met…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New ablation catheter shows promise for treating irregular heartbeat
Disease control CompletedThis study tested a new type of catheter (a thin tube) that uses heat to destroy tiny areas of heart tissue causing irregular heartbeats in people with paroxysmal atrial fibrillation (AFib). The catheter has a cooling system to prevent overheating. The trial involved 415 particip…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New sphincter implant shows promise for Post-Prostate surgery leakage
Disease control CompletedThis study tested an artificial urinary sphincter implant in 145 men with stress urinary incontinence after prostate surgery. The device is designed to mimic natural bladder control by opening and closing the urethra. Researchers measured how many men had at least a 50% reduction…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New heart zapping device shows promise for stubborn AFib
Disease control CompletedThis study tested the FARAPULSE system, a device that uses short electrical pulses to destroy small areas of heart tissue causing abnormal rhythms in people with persistent atrial fibrillation (AFib). The trial enrolled 669 adults with drug-resistant, symptomatic persistent AFib.…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Heart device healing checked with advanced scans
Disease control CompletedThis study looked at how tissue covers the WATCHMAN FLX Pro device after it is placed in the heart to prevent strokes in people with atrial fibrillation. 43 participants received the implant and had follow-up CT scans and echocardiograms to check for any thickening on the device …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Freezing out AFib: new device tested in Real-World study
Disease control CompletedThis study looked at how safe and effective a freezing treatment (cryoablation) is for people with a type of irregular heartbeat called paroxysmal atrial fibrillation (AFib). The treatment uses a device called POLARx to freeze heart tissue and stop the faulty signals causing AFib…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New device shows promise in preventing strokes for heart patients
Disease control CompletedThis study tracked 949 patients with non-valvular atrial fibrillation who received the WATCHMAN FLX Pro device, a small implant that closes off a part of the heart to reduce stroke risk. The goal was to see how well the device works in everyday medical practice, focusing on safet…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New balloon treatment shows promise for leg artery blockages
Disease control CompletedThis study tested a special balloon coated with a drug to open blocked arteries in the leg. 123 people with leg pain from poor blood flow were treated. The goal was to see if the balloon is safe and keeps arteries open for at least a year.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Gel shield spares rectum during prostate radiation in small study
Disease control CompletedThis study looked at a gel called SpaceOAR that is injected between the prostate and rectum before radiation therapy for prostate cancer. The gel creates a temporary space to protect the rectum from radiation damage. Fifteen men with early-stage prostate cancer took part, and the…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a tiny implant replace daily blood thinners for AF patients?
Disease control CompletedThis study tested whether a device called WATCHMAN FLX, which closes a small pouch in the heart, is a good alternative to blood thinners for preventing strokes in people with atrial fibrillation (AF) after a heart procedure called ablation. About 1,600 high-risk patients were enr…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 26, 2026 18:32 UTC
-
New heart mapping tech tested for AFib treatment
Disease control CompletedThis study tested a new mapping feature (FARAVIEW™) used with a pulsed field ablation catheter (FARAWAVE NAV™) to treat atrial fibrillation. Fifty patients with symptomatic AFib that didn't respond to medication were included. The goal was to see how well doctors could isolate th…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 26, 2026 17:41 UTC
-
Spinal device eases diabetic nerve pain in small study
Symptom relief CompletedThis study tested whether a spinal cord stimulation device can reduce chronic leg pain caused by diabetic neuropathy. Twenty-eight people with diabetes received the implant and reported their pain relief and overall improvement over 12 months. The goal was to see if this device c…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Heat waves for pain? RF ablation study shows promise
Symptom relief CompletedThis completed study looked at how well radiofrequency ablation (a procedure that uses heat to calm pain nerves) works for people with chronic pain. 298 participants were treated with a Boston Scientific device and then rated their improvement. The goal was to see real-world resu…
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Laser dusting vs breaking: which kidney stone technique wins?
Symptom relief CompletedThis study tested two ways to use a laser to remove kidney stones: breaking them into pieces or turning them into dust. Twenty adults with kidney stones took part. The goal was to see which method clears stones better, is faster, and causes fewer complications.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New brain pacemaker programming shows promise for Parkinson's relief
Symptom relief CompletedThis study tested a new way to program deep brain stimulation (DBS) in 15 people with Parkinson's disease. The goal was to see if this different programming pattern could improve their quality of life. Participants already had DBS devices implanted and were monitored for changes …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Bypass without surgery: new scope procedure helps cancer patients eat again
Symptom relief CompletedThis study tested a new procedure that uses an endoscope to create a bypass around a stomach blockage caused by advanced cancer. The goal was to help people eat and drink without major surgery. Fifty-one participants with inoperable cancer and severe blockage were enrolled. The p…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New laser zaps away prostate problems in minutes
Symptom relief CompletedThis study tested a special laser to treat an enlarged prostate (BPH) in 20 men who needed surgery. The laser was used to vaporize extra prostate tissue, and the men were followed for 3 months to see how well it worked and if there were side effects. The goal was to find out if t…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Chronic pain patients share Real-Life device results in new study
Knowledge-focused CompletedThis study gathered information from 73 adults with chronic pain who were already using or planning to use an approved medical device (like a spinal cord stimulator) for their pain. Researchers asked participants to report their pain levels on a 0-10 scale and other outcomes duri…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Stent registry shows Real-World results for blocked ureters
Knowledge-focused CompletedThis completed registry followed 379 people who received a Boston Scientific ureteral stent to treat a blocked ureter. The goal was to see how well the stent worked and if it caused any serious side effects. Patients also reported on their quality of life. The study provides real…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
New registry tracks Drug-Coated Balloon's Real-World performance in chinese heart patients
Knowledge-focused CompletedThis completed registry study followed 500 Chinese patients who received the Agent DCB, a paclitaxel-coated balloon catheter, during a heart procedure to open blocked arteries. The goal was to collect real-world data on heart-related events like heart attacks or repeat procedures…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC